scPharmaceuticals Inc. Common Stock
SCPH Real Time Price USDRecent trades of SCPH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SCPH's directors and management
Government lobbying spending instances
-
$12,500 Oct 17, 2024 Issue: Health Issues Medicare/Medicaid
-
$12,500 Jul 15, 2024 Issue: Health Issues Medicare/Medicaid
-
$12,500 Apr 17, 2024 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same Jul. 30, 2024
-
Patent Title: Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same Jun. 04, 2024
-
Patent Title: Concentrated liquid pharmaceutical formulations of furosemide Feb. 07, 2023
-
Patent Title: Concentrated liquid pharmaceutical formulations of furosemide Jan. 24, 2023
-
Patent Title: Concentrated liquid pharmaceutical formulations of furosemide Nov. 15, 2022
-
Patent Title: Pharmaceutical formulations for subcutaneous administration of furosemide Sep. 06, 2022
-
Patent Title: Pharmaceutical formulations for subcutaneous administration of furosemide Apr. 30, 2019
-
Patent Title: Pharmaceutical formulations for subcutaneous administration of furosemide Feb. 06, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SCPH in WallStreetBets Daily Discussion
Recent insights relating to SCPH
Recent picks made for SCPH stock on CNBC
ETFs with the largest estimated holdings in SCPH
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SCPH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.